Log in

Oventus Medical Stock Price, News & Analysis (ASX:OVN)

Today's Range N/A
50-Day Range
A$0.24
MA: A$0.43
A$0.64
52-Week Range N/A
Volume72,500 shs
Average VolumeN/A
Market Capitalization$48.20 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of sleep apnoea and snoring in Australia. It offers O2Vent W, a winged-style device to stabilize the jaw; O2Vent T devices that titrate lower jaw forward; O2Vent Mono, a device that advances the lower jaw to a fixed position; and O2Vent nylon and O2Vent ONEPAP appliances. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 7 3831 8866

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$331,837.00
Book ValueA$0.07 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$48.20 million
Next Earnings DateN/A
OptionableNot Optionable

Receive OVN News and Ratings via Email

Sign-up to receive the latest news and ratings for OVN and its competitors with MarketBeat's FREE daily newsletter.


Oventus Medical (ASX:OVN) Frequently Asked Questions

What is Oventus Medical's stock symbol?

Oventus Medical trades on the ASX under the ticker symbol "OVN."

Has Oventus Medical been receiving favorable news coverage?

Media headlines about OVN stock have trended somewhat negative on Saturday, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Oventus Medical earned a media sentiment score of -1.5 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Oventus Medical.

Who are some of Oventus Medical's key competitors?

Who are Oventus Medical's key executives?

Oventus Medical's management team includes the folowing people:
  • Dr. Christopher Patrick Hart, Co-Founder, MD, CEO & Exec. Director
  • Mr. Neil Anderson, Co-Founder, CTO & Exec. Director (Age 60)
  • Daniel Parry, Chief Financial & Operations Officer
  • Mr. Stephen Denaro BCom, GradDipApp CG, CA, MAICD, Company Sec. & Director
  • Robin Randolph, VP Marketing & Operations of North America

How big of a company is Oventus Medical?

Oventus Medical has a market capitalization of $0.00 and generates $331,837.00 in revenue each year. View Additional Information About Oventus Medical.

What is Oventus Medical's official website?

The official website for Oventus Medical is http://www.oventus.com.au/.

How can I contact Oventus Medical?

The company can be reached via phone at 61 7 3831 8866.


MarketBeat Community Rating for Oventus Medical (ASX OVN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  13
MarketBeat's community ratings are surveys of what our community members think about Oventus Medical and other stocks. Vote "Outperform" if you believe OVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OVN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: Straddles

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel